Structural biology of the alternative pathway convertase

被引:65
作者
Xu, YY
Narayana, SVL
Volanakis, JE
机构
[1] BSRC Alexander Fleming, Vari 16672, Greece
[2] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Ctr Macromol Crystallog, Birmingham, AL USA
[4] Univ Alabama Birmingham, Sch Optometry, Birmingham, AL USA
关键词
D O I
10.1034/j.1600-065X.2001.1800111.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement convertases are bimolecular complexes expressing protease activity only against C3 and C5. Their action is necessary for production of the biological activities of the complement system. Formation of these complexes proceeds through sequential protein-protein interactions and proteolytic cleavages of high specificity. Recent structural, mutational and functional data on factors D and B have significantly enhanced our understanding of the assembly, action, and regulation of the alternative pathway convertase. These processes were shown to depend critically on conformational changes, only some of which are reversible. The need for such changes is dictated by the zymogen-like configurations of the active centers of these unique serine proteases. The structural determinants of some of these changes have been defined from structural and mutational analyses of the two enzymes. Transition of factor D from the zymogen-like to the catalytically active conformation is completely reversible, while the active conformation of the catalytic center of the Bb fragment of factor B is irreversibly attenuated to a great extent on dissociation of the convertase complex. Both mechanisms contribute to the regulation of the proteolytic activity of these enzymes. Additional studies are necessary for a complete description of the elegant mechanisms mediating these processes.
引用
收藏
页码:123 / 135
页数:13
相关论文
共 95 条
[31]  
HORIUCHI T, 1989, J IMMUNOL, V142, P2105
[32]  
HORIUCHI T, 1993, MOL IMMUNOL, V30, P1587
[33]  
Hourcade DE, 1999, J IMMUNOL, V162, P2906
[34]   ANALYSIS OF THE SHORT CONSENSUS REPEATS OF HUMAN-COMPLEMENT FACTOR-B BY SITE-DIRECTED MUTAGENESIS [J].
HOURCADE, DE ;
WAGNER, LM ;
OGLESBY, TJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19716-19722
[35]   A conserved element in the serine protease domain of complement factor B [J].
Hourcade, DE ;
Mitchell, LM ;
Oglesby, TJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25996-26000
[36]   A BINDING INTERFACE ON THE I-DOMAIN OF LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1) REQUIRED FOR SPECIFIC INTERACTION WITH INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) [J].
HUANG, CC ;
SPRINGER, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19008-19016
[37]   STUDIES ON ESTEROLYTIC ACTIVITY OF ALTERNATIVE COMPLEMENT COMPONENT FACTOR-B [J].
IKARI, N ;
HITOMI, Y ;
NIINOBE, M ;
FUJII, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 742 (02) :318-323
[38]   Structures of native and complexed complement factor D: Implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity [J].
Jing, H ;
Babu, YS ;
Moore, D ;
Kilpatrick, JM ;
Liu, XY ;
Volanakis, JE ;
Narayana, SVL .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 282 (05) :1061-1081
[39]   Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D [J].
Jing, H ;
Macon, KJ ;
Moore, D ;
DeLucas, LJ ;
Volanakis, JE ;
Narayana, SVL .
EMBO JOURNAL, 1999, 18 (04) :804-814
[40]   New structural motifs on the chymotrypsin fold and their potential roles in complement factor B [J].
Jing, H ;
Xu, YY ;
Carson, M ;
Moore, D ;
Macon, KJ ;
Volanakis, JE ;
Narayana, SVL .
EMBO JOURNAL, 2000, 19 (02) :164-173